Withdrawal of Posicor from market.
SoRelle
R
R
D001562:Benzimidazoles / Q000009:adverse effects*; D002121:Calcium Channel Blockers / Q000009:adverse effects*; D017277:Drug Approval; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D020748:Mibefradil; D011358:Product Surveillance, Postmarketing; D013764:Tetrahydronaphthalenes / Q000009:adverse effects*
D001562:Benzimidazoles; D002121:Calcium Channel Blockers; D013764:Tetrahydronaphthalenes; D020748:Mibefradil